CD8A and neoplasm: Using a subcutaneous tumor model with the T-lymphoma cell line KARPAS299 (Figure 5A,B), our studies showed that there was no difference in the effect of CD26 2G CAR-T-cells and CD8 2G control cells on tumor growth.